Action of atrop-abyssomicin C as an inhibitor of 4-amino-4-deoxychorismate synthase PabB
Action of atrop-abyssomicin C as an inhibitor of 4-amino-4-deoxychorismate synthase PabB
复制标题
DOI:
10.1002/anie.200701836
复制
发表时间:
2007-01-01
影响因子:
16.6
通讯作者:
Suessmuth, Roderich D.
中科院分区:
文献类型:
--
作者:
Keller, Simone;Schadt, Heiko S.;Suessmuth, Roderich D.
Among biosynthetic pathways, chorismate is an important and central biosynthetic metabolite that branches off to the biosynthesis of aromatic amino acids Trp, Tyr, and Phe, but also to p-aminobenzoic acid (pABA).[1] p-Aminobenzoic acid is a component of the biosynthesis of tetrahydrofolate. Corresponding biosynthesis enzymes of pABA and tetrahydrofolate occur in many microorganisms and parasites, but not in humans, which makes pABA biosynthesis an interesting target for anti-infective agents. Prominent synthetic inhibitors of the tetrahydrofolate pathway are sulfonamides and trimetoprim.[2]Recent screening efforts in the pABA biosynthesis pathway led to the isolation of abyssomicins B, C (1), and D (4)[3, 4] from the gram-positive marine actinomycete Verrucosispora AB-18-032 (Scheme 1). Out of the three metabolites, abyssomicin C has been described as the only active component against gram-positive bacteria including pathogenic Staphylococcus aureus strains. Because of the attractive structure, several synthetic chemistry groups have directed their interests towards the total synthesis of abyssomicinC.[5–8] Two successful total syntheses have been published so far, the first by Sorensen and co-workers [5] and the second by Nicolaou and Harrison.[6, 8]